MiMedx Group, Inc (MDXG) Financials
MDXG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 221.7 million | 66.0 million |
2023-12-31 | 239.0 million | 96.3 million |
2023-09-30 | 189.0 million | 187.7 million |
2023-06-30 | 176.4 million | 189.0 million |
MDXG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 6.8 million | ? |
2023-12-31 | 9.8 million | 4.2 million |
2023-09-30 | 12.1 million | 4.4 million |
2023-06-30 | 7.4 million | 4.1 million |
MDXG Net Income
No data available :(
MDXG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 48.5 million | - | - |
2023-12-31 | 82.0 million | - | - |
2023-09-30 | 81.2 million | - | - |
2023-06-30 | 68.7 million | - | - |
MDXG Shares Outstanding
MDXG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | - | 2.8 million | - | - |
2023-12-31 | 481000 | -5.5 million | 54.4 million | - |
2023-09-30 | 649000 | 3.2 million | 52.6 million | - |
2023-06-30 | 348000 | 8.5 million | 51.9 million | - |
MDXG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 84.7 million | 13.0 million |
2023-12-31 | 86.8 million | 13.8 million |
2023-09-30 | 81.7 million | 14.8 million |
2023-06-30 | 81.3 million | 13.6 million |
MDXG
Price: $7.15
52 week price:
Earnings Per Share: 0.43 USD
P/E Ratio: -389
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 1.1 billion